Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP894557.RAgaPEwht_WHrdLMQRW7_UX_TzE4UG8lfwWThg1_1GW2M130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP894557.RAgaPEwht_WHrdLMQRW7_UX_TzE4UG8lfwWThg1_1GW2M130_assertion type Assertion NP894557.RAgaPEwht_WHrdLMQRW7_UX_TzE4UG8lfwWThg1_1GW2M130_head.
- NP894557.RAgaPEwht_WHrdLMQRW7_UX_TzE4UG8lfwWThg1_1GW2M130_assertion description "[Antisense oligonucleotides (oligos) directed against mRNA-encoding, transforming growth factor-alpha (TGF-alpha) and the epidermal growth factor receptor (EGFR), have been shown to significantly inhibit in vitro and in vivo growth of prostate tumor models.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP894557.RAgaPEwht_WHrdLMQRW7_UX_TzE4UG8lfwWThg1_1GW2M130_provenance.
- NP894557.RAgaPEwht_WHrdLMQRW7_UX_TzE4UG8lfwWThg1_1GW2M130_assertion evidence source_evidence_literature NP894557.RAgaPEwht_WHrdLMQRW7_UX_TzE4UG8lfwWThg1_1GW2M130_provenance.
- NP894557.RAgaPEwht_WHrdLMQRW7_UX_TzE4UG8lfwWThg1_1GW2M130_assertion SIO_000772 12616956 NP894557.RAgaPEwht_WHrdLMQRW7_UX_TzE4UG8lfwWThg1_1GW2M130_provenance.
- NP894557.RAgaPEwht_WHrdLMQRW7_UX_TzE4UG8lfwWThg1_1GW2M130_assertion wasDerivedFrom befree-20140225 NP894557.RAgaPEwht_WHrdLMQRW7_UX_TzE4UG8lfwWThg1_1GW2M130_provenance.
- NP894557.RAgaPEwht_WHrdLMQRW7_UX_TzE4UG8lfwWThg1_1GW2M130_assertion wasGeneratedBy ECO_0000203 NP894557.RAgaPEwht_WHrdLMQRW7_UX_TzE4UG8lfwWThg1_1GW2M130_provenance.